Dr Martine Cérutti

Dr. Martine Cérutti, Head of the CNRS unit «Baculoviruses and Therapy» laboratory. She is a specialist in production of recombinant antibodies or proteins for therapeutic use and has made major contributions in the development of drug discovery and immunotherapy

  • The success rate 99%
  • Presence 92%
  • Presence test 74%

Dr Martine Cérutti

  • Appreciation 93%
  • Was treated 98%
  • Presence 2 45%

Dr. Martine Cérutti, Head of the CNRS unit «Baculoviruses and Therapy» laboratory. She is a specialist in production of recombinant antibodies or proteins for therapeutic use and has made major contributions in the development of drug discovery and immunotherapy. Dr. Cérutti’s group is part of several French research consortia: (i) the CNRS Research Group (Groupe de Recherche; GDR) «Antibodies and therapeutic targeting» that associates many academic and private-sector laboratories specialized in the discovery and production of therapeutic antibodies; (ii) the «MabImprove» Laboratory of Excellence project (Laboratoire d’excellence; LabEx) that brings together several academic laboratories, physicians and researchers for the discovery and optimization of therapeutic antibodies; and finally She has co-authored 98 peer-reviewed scientific publications and he was named in many patent applications covering the production of antibodies in baculovirus.

call us

For scientific questions, don’t hesitate to contact us by email: [email protected]

For administrative questions, contact our dedicated service at: [email protected]

Phone : +33658540882

email : [email protected]

14 + 14 =